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of nanosilver applications gave insights into different 
approaches of risk assessment of nanomaterials to be per-
formed under the various regulatory frameworks.
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Analyzing nanoparticles in complex matrices reveals 
challenging
The recent recommendation of the European Commission on 
the definition of nanomaterials is emphasizing the determi-
nation of the non-bound particles as a number size distribu-
tion from 1 to 100 nm (EU Commission 2011). While this 
definition is precise from a legal point of view, it causes sub-
stantial constraints as there are very few or no easy analytical 
methods to measure this variable without any conversions. An 
additional limitation is due to the fact that currently only a 
few already existing analytical techniques can reach far down 
to 1 nm as required by the definition. Thus, the detailed ana-
lytical characterization of the basic particle inherent proper-
ties like size, shape and surface area should stand at the very 
beginning of any further considerations. A thorough charac-
terization of the nanoparticles especially in complex matrices 
is still the biggest challenge in this research area and could 
potentially become a pitfall for further innovation in the field.
Analytical methods, limitations and repository materials
Douglas Gilliland (Joint Research Center JRC—Institute 
for Health and Consumer Protection IHCP, Italy) discussed 
Abstract In light of the broad spectrum of products con-
taining nanosilver, the harmfulness of nanosilver to human 
health and the environment was intensively discussed at a 
conference held in February 2012 at the BfR. The confer-
ence agenda covered the aspects of analytics of nanosil-
ver materials, human exposure and toxicology as well as 
effects on microorganisms and the environment. The dis-
cussion recovered major gaps related to commonly agreed 
guidelines for sample preparation and central analytical 
techniques. In particular, the characterization of the nano-
particles in complex matrices was regarded as a challenge 
which might become a pitfall for further innovation and 
application. Historical and anecdotal records of colloidal 
silver have been sometimes taken as empirical proof for the 
general low toxicity of nanosilver. Yet as reported herein, a 
growing number of animal studies following modern per-
formance standards of toxicity testing have been carried 
out recently revealing well-characterized adverse effects 
on different routes of exposure in addition to argyria. Fur-
thermore, recent approaches in exposure assessment were 
reported. However, consumer exposure scenarios are only 
starting to be developed and reliable exposure data are still 
rare. It was further widely agreed on the workshop that 
the use of silver may lead to the selection of silver resist-
ant bacteria. With respect to its environmental behavior, it 
was suggested that nanosilver released to wastewater may 
have negligible ecotoxicological effects. Finally, the pres-
entations and discussion on risk assessment and regulation 
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the currently available analytical methods. Electron micros-
copy (EM) enables visualizing of the nanoparticles itself 
(Linsinger et al. 2012). Although this technique is usually 
regarded as the standard method for particle size determi-
nation, this is only unrestrictedly true for very ideal sam-
ples. If the composition of the analyzed sample becomes 
more complex, for example, due to the formation of aggre-
gates, the determination of the particle size distribution by 
EM is rather challenging.
Other commonly used techniques are light scatter-
ing methods with dynamic light scattering (DLS) being 
the principal one. For monodisperse samples, DLS can be 
used to obtain quite precise size measurements, but for the 
analysis of complex mixtures of “real-life samples,” this 
technique has some severe limitations. In particular, in the 
presence of larger particles, a heavy weighting toward the 
larger particle sizes occurs.
One scientifically accepted alternative overcoming this 
difficulty is using a whole suite of appropriate techniques 
in a tiered order. The JRC/IHCP recommends a multi-tech-
nique approach integrating optical methods, direct imaging 
and precise separation methods. One preferred way of ana-
lyzing a composition of nanoparticles is the detachment of 
size separation from the actual size measurement in order 
to determine the relative quantities in conjunction with the 
relative particle size. For example, techniques like asym-
metric flow field-flow fractionation (AF4) or centrifugal 
particle sedimentation (CPS) are used to fractionate parti-
cles into different portion sizes. The purpose of these com-
paratively gentle separation techniques is the full recovery 
of particles in their separated state. At this point, a wide 
variety of different detectors can be used for a more precise 
nanoparticle characterization. Examples for such detec-
tors, which can be combined with AF4, are the refractive 
index, DLS and the ultraviolet/visible (UV/Vis) detector. 
To achieve ultimate sensitivity in case of inorganic nano-
particles such as silver, AF4 can be connected online to the 
inductively coupled plasma mass spectrometry (ICP-MS).
At JRC, the following techniques are used for in-depth 
analyses of the properties of nanoparticles at the molecular 
level: X-ray photoelectron spectroscopy (XPS) to charac-
terize the surface chemistry of the nanoparticles; synchro-
tron radiation circular dichroism (CD) to study the various 
alterations of the protein corona that would occur during 
interaction of the particles (Laera et al. 2011) and nuclear 
magnetic resonance (NMR) spectroscopy to monitor any 
changes which can occur in the conformation of ligands.
Besides instrumentation, the absolute quantification 
of nanoparticles, the validation of the analytical method 
of choice and the calibration of the analytical equip-
ment require the availability of appropriately character-
ized reference materials. In the absence of certified ref-
erence materials, which are so far restricted to gold and 
silica nanomaterials, the creation of a repository of well-
characterized representative nanomaterials is essential for 
the implementation of any analytical test methods. The 
nanosilver repository material NM300 K provided by the 
JRC is well characterized, monodispersed, highly concen-
trated (10 % w/w) with more than 90 % of the material 
being below 20 nm in size (maxima 10–15 nm). This has 
been achieved by applying a mixture of two different sur-
factants as stabilizing agents, that is, 4 % w/w of each poly-
oxyethylene glycerol trioleate and Tween 20®.
As nanoparticles normally interact very quickly with 
their surrounding media, thereby altering their physico-
chemical properties, measurement of the changes in parti-
cle size distribution in different media is essential for the 
understanding of the toxicological effects that may occur. 
The following results from studies carried out by the JRC 
may illustrate such alterations. In the presence of a high 
ionic content solution, the nanosilver particle dispersion 
becomes unstable. After 30 min in such an environment, 
the material reveals hardly detectable, and after 60 min, 
no nanoparticles could be observed anymore either due to 
aggregation or complete dissolution in the sample. Con-
versely, when the nanoparticles are kept in a protein-rich 
environment, like cell culture media, even after 12 h, there 
is a significant amount of material left in the mere mono-
dispersed state and only after 48 h most of the material 
begins to disappear from the nanorange. In addition, silver 
nanoparticles may also remain relatively stable even after 
24 h in water possessing low ionic strength. Increasing the 
ionic content by using water of ascending degrees of hard-
ness, the dissolution or aggregation level of nanosilver par-
ticles is simultaneously rising until particles are no more 
detectable after 24 h. The addition of humic acid revealed 
as very powerful stabilizing agent, even when applied in 
very small quantities such as 10 μg per ml. Under such 
conditions, 50 % of the originally monodispersed nanopar-
ticles remain preserved over 24 h. Studying the dissolution 
rate of silver particles stabilized with maltose in relation to 
particle size, it was found that the particles dissolve only 
between 5 and 10 % in 24 h, and even after around 7 days 
in solution only between 20 and 50 % of the silver parti-
cles had been dissolved. Although the larger particles had 
the lowest dissolution rate, it is assumed that this effect is 
only due to the changed surface-to-volume ratio, because 
the difference between larger and smaller particles was not 
nearly as significant as expected.
Experimental challenges analyzing complex matrices
In his talk, Stefan Weigel (RIKILT, The Dutch Institute for 
Food Safety, The Netherlands) was focusing on the analysis 
of silver nanoparticles in complex matrices. Recent expo-
sure assessments are hampered by the limited availability 
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of specific methods to determine size and elemental com-
position of complex matrices as exemplified by consumer 
products and food. Consequently, there is hardly any vali-
dated data on the presence of silver nanoparticles in such 
products.
A promising technique might be the single particle 
inductively coupled plasma–mass spectrometry (sp ICP-
MS) as it represents a tool for the determination of both 
the number and mass concentration of silver nanoparticles. 
Instrument settings and nanoparticle concentration in the 
sample will be adjusted in a way that individual nanoparti-
cles are being recorded. While the number of peaks corre-
sponds to the particle number concentration, the intensity of 
the signal is proportional to the mass of the particles (Pace 
et al. 2011). Under the assumption of spherical non-porous 
particles, which are not composed of different materials, it 
is possible to calculate the original size of the particles. The 
method has successfully been applied to, for example, envi-
ronmental, biological and food samples. Hyphenated sep-
aration and detection techniques have proven to be suited 
for the quantitative determination of silver nanoparticles 
in complex media. In particular, AF4 is commonly used 
for the separation of nanoparticles according to their sizes 
and can be coupled online to a variety of different detectors 
such as UV, light scattering and ICP-MS (von der Kammer 
et al. 2011). Screening methods are a cost-efficient alter-
native to the aforementioned techniques and recently a 
biosensor method for the detection of silver nanoparticles 
has been reported (Rebe et al. 2012). This surface plasmon 
resonance-based assay uses a human metallothionein as a 
recognition element on the sensor chip surface.
Characterization of nanoparticles is often carried out in 
pure suspensions with sizing techniques that are not ele-
ment specific (e.g., light scattering, particle tracking anal-
ysis or EM) and/or with element-specific methods (e.g., 
AAS, ICP-MS, ICP-OES) that are not size specific (deter-
mination of bulk concentration). In application media and 
even more in vivo, the nanoparticles may change consid-
erably. Agglomeration, aggregation, dissolution and attach-
ment to proteins have been described. Therefore, it is 
essential to characterize nanoparticles in cell culture media 
or under in vivo conditions by using size and element-
specific methods or a combination of methods to achieve a 
meaningful answer to the experimental question addressed.
A further specific issue is the existence of different solid 
forms of silver species that via dissolution can be partly 
transformed into other species. Thus, elemental silver (Ag0) 
slowly dissolves and depending on the chemical envi-
ronment, the resulting Ag+ ions may form soluble com-
plexes such as AgCl2−, AgCl32−, [Ag(NH3)2]+, covalent 
adducts with thiol group containing compounds (e.g., glu-
tathione, cysteine, proteins) or insoluble salts (AgCl, Ag2S) 
which may precipitate as particulates (Liu et al. 2010). 
Furthermore, Ag+ can be easily reduced to Ag0, for exam-
ple, by glucose, thus leading to de novo formation of Ag0 
nanoparticles. It therefore becomes crucial to determine the 
identity of the chemical species in which silver nanoparti-
cles are present in the test tube.
In summary, despite the already-mentioned difficulties, 
a number of different approaches for the detection and 
characterization of nanoparticles in complex matrices have 
yet been developed or are currently under development. 
However, sample preparation is one critical issue for such 
samples and the formation of artifacts and matrix effects is 
a common problem (Dudkiewicz et al. 2011). Furthermore, 
the validation of methods for the analysis of silver nano-
particle’s size, distribution and overall presence is currently 
severely hampered by the absence of any certified reference 
materials, both for pure dispersions as well as in various 
matrices.
Consumer exposure scenarios are only starting  
to be developed
Irrespective of the claimed benefit of nanomaterials, their 
utilization must be safe. As part of the overall risk assess-
ment exposure characterization comprises the systematic 
identification of potential exposure scenarios and the esti-
mation of exposure levels via oral, dermal and inhalative 
routes. Direct exposure to pristine manufactured nanoma-
terials is most likely for workers in industrial settings when 
handling nanomaterials without protection measures or 
by accidental release from enclosed automatic production 
systems. Consumers are mostly intentionally or unavoid-
ably exposed to nanomaterials when using the increasing 
variety of products meanwhile containing these materi-
als, such as lotions, antiperspirants, shoe sprays and food 
package materials. Next to the content, an assessment of 
the resulting exposure will have to take into account the 
material humans come into contact with. The four talks in 
this session covered current results of research on textile 
functionalization, nanoparticle abrasion from surface coat-
ings and content, release and uptake assessments for silver 
and nanomaterials from food, dietary supplements and con-
sumer products. For the purpose of this review, their con-
tents have been sorted according to exposure routes.
Inhalative exposure
Among other applications, silver is used as a biocidal agent 
in sprays to treat shoes and feet, and to act as antiperspi-
rant which can result in exposure via the respiratory tract. 
Natalie von Götz (ETH Zürich, Switzerland) reported the 
levels of 6–9 ppm silver and below the detection limit in 
the solutions of sprays investigated at the ETH Zürich and 
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EMPA (Lorenz et al. 2011a). Subsequent TEM analysis of 
the corresponding aerosols indicated no silver particles. It 
was argued that this finding might be due to the silver hav-
ing been a mixture of silver salts and nanosilver particles, 
and would need to be elucidated further. A recent US study 
for comparison detected up to 56 ng nanosilver per spray 
action in aerosols (Quadros and Marr 2011). A remark-
able finding reported by von Götz was that the investigated 
pump spray did not generate particles in aerosols measura-
ble with a scanning particle mobility sizer after thermodes-
orption in 80-cm distance to the spraying nozzle. The emit-
ted droplets dropped down by gravity before they reached 
the detector. However, the propellant gas driven sprays 
produced many inhalable nanoparticles or nanoscaled drop-
lets irrespective of the original nanoparticle content in the 
dispersion.
In tiered release experiments, Michael Stintz and co-
workers (Technical University of Dresden, Germany) 
applied increasingly stressing surface treatments to coated 
parquet. In a first tier, abrasers with sand stone wheels 
achieved a low-velocity scratching treatment used to sim-
ulate an abrasion process comparable to walking on the 
parquet with sandy shoes. Parquet coatings contained zinc 
oxide in nanoform (clear coat) and/or titanium dioxide 
as whitening pigment. In this setting, the treated surfaces 
released negligible amounts of nanoparticles because of 
the low velocity and the elasticity of the clear coat (Vor-
bau et al. 2009). In the second tier, a high-speed rotating 
sander was used. As a major result, it was impossible to 
distinguish between the generated aerosols from several 
surface coatings with nanoparticles (zinc oxide and iron 
oxide) and from those without (Göhler et al. 2010). In a 
third step, furniture, parquet and architectural coatings 
were artificially aged by UV radiation in a dry atmosphere 
(2,000 h at 50 °C; European Standard for indoor aging) 
prior to a fully encapsulated sanding procedure. In essence, 
no free nanoparticle additives (e.g., ZnO) were observed 
by applying extensive analytical procedures (scanning/
transmission electron microscopy and energy disperse 
X-ray spectroscopy, SEM, TEM, EDX), despite consider-
able sanding-induced release of particles in the nanoscale. 
The TEM images revealed that the nanoparticle additives 
remained firmly embedded in the surrounding matrix 
material of larger particles, hence the nanoscaled particles 
observed originated solely from the pure matrix material. 
Irrespective of the kind of surface coating, additional nano-
particle additives did not have any impact on particle size 
distribution patterns. However, the patterns and generated 
amounts were significantly altered by aging. In these cases, 
more particles were detected and a broader particle size 
distribution was noted. Stintz estimated that up to 150.000 
respirable particles per cm3 can be produced through sand-
ing procedures. Reasoning that comparably high particle 
concentrations are reached in heavy traffic roads during 
rush hour, he considered it remarkable that special breath 
masks are recommended especially for long-time exposure 
of professional sanding workers (Hillemann et al. 2006). 
Besides standardized procedures for the mechanical treat-
ment of surfaces exist, the workshop did not address a har-
monized strategy to determine number concentrations at 
the workplace (Kuhlbusch et al. 2011).
Dermal exposure
The intact skin has been shown to be an effective barrier 
for nanoparticles. For silver nanoparticles, skin penetration 
rates less than 0.01 % have been published (Larese et al. 
2009). Despite such low rates, the internal exposure result-
ing from high external burden may still be considerable. 
Lorenz and co-workers have recently published an assess-
ment of potential exposure via cosmetics and personal care 
products taking into account the behavior patterns of Ger-
man consumers (Lorenz et al. 2011b). However, the authors 
did not include creams in their reflections on silver. Based 
on a reported common application of 0.8 g each on hands 
and face trice a day and a content of 0.1 % silver, von Götz 
calculated an external exposure of 4.500 μg silver/day. 
While internal exposures can be assessed from external 
burden on the basis of uptake factors, von Götz emphasized 
that up to date, irrespective of the route regarded, these fac-
tors have been determined in only a few studies, if any. Fur-
thermore, these have usually been conducted with a specific 
nanoparticle material and intact skin. This should be taken 
into account when employing the factors as they are prone 
to be influenced by changes of characteristics, such as size, 
surface coating and form of nanoparticles. In addition, con-
ditions with reduced skin barrier function may enlarge the 
taken up fraction of particles.
Nina Keusgen (RWTH Aachen Institute for Interactive 
Materials Research, Germany) presented the results on 
nanosilver functionalization of textiles for medical pur-
poses. The investigated functionalization techniques are 
based on the 2–10 nm nanosilver being alternatively: (1) 
incorporated into polyvinyl alcohol fibers, (2) deposited 
on organic or inorganic nanocarriers which are fixed to the 
textile surface via ionic interaction and/or polymers and (3) 
incorporated in microgel containers to form nanogels for 
textile finishing. 0.75 % w/w of 2–8 nm nanosilver bound 
to polyvinyl alcohol fibers was found to inhibit bacterial 
growth in the fiber efficiently. Fastness and efficiency of 
the functionalization have been shown to depend on the 
employed carriers and binding technology. A polycationic 
finishing prevented elution best. All developed techniques 
showed superior performance in comparison to a cot-
ton sample finished with a commercial silver salt-based 
product.
2253Arch Toxicol (2013) 87:2249–2262 
1 3
Oral exposure
Richard Winterhalter (Bavarian Institute for Health and 
Food Safety, Germany) elucidated sources of nanoscaled 
materials in food and food supplements. In essence, 
nanoscaled silver could occur due to unintended contami-
nation during production processes, migration from food 
contact materials (FCM) or from deliberate inclusion. In 
regard to the last two sources, he explained that within the 
European Union, silver as food additive is only author-
ized for the specific use to make food surfaces more shiny 
(sweets), which cannot be achieved by nanosilver. Further-
more, up-to-date employment of nanosilver in FCM and in 
preparations marketed as food supplements is not assessed 
in the European Union. However, products containing them 
can be obtained via the Internet. The increasing applica-
tion of nanotechnology and synthetic nanomaterials or 
nanoparticles in the production of food and FCM presents 
a challenge for food safety authorities. The Bavarian Health 
and Food Safety Authority and the Fraunhofer Institute for 
Process Engineering and Packaging have therefore set up 
a project which aims to measure nanoparticle migration 
from food packages into food, to characterize nanoparticles 
in food and food supplements and to develop the required 
sensitive and specific analytics for these tasks. An asym-
metric flow field-flow fractionation (AF4) in combination 
with UV and multi-angle light scattering (MALS) detection 
has been developed for concentration measurement and 
characterization of silica and silver nanoparticles. While 
further method development will be needed for refine-
ment of cross-flow rates, solvents and sample preparation, 
its first application to colloidal silver preparations meas-
ured concentrations generally falling significantly short of 
labeled contents. Additional information given during the 
following discussions was that migration experiments for 
titanium from plastic bottles did not lead to levels in the 
food stimulants exceeding the reference value. However, 
reasoning that there are studies revealing globally marketed 
FCM may release up to a few percent of silver, such results 
should not be generalized.
Von Goetz et al. (2013) also presented results on silver 
release from FCM. Using ICP-MS and TEM, her group 
examined four food containers bought in the United States 
and Germany claiming to contain silver in their material 
or rubber sealing. With a detection limit of 0.1 μg/g mate-
rial, this claim could only be verified for two products (18.7 
and 37.1 μg/g plastic). Both were subsequently subjected 
to release experiments. Employing water, ethanol and ace-
tic acid as food stimulants, silver release was observed for 
one box. Acetic conditions resulted in the highest yield 
(30 ng/cm2). Remarkably, using MD-ICP-MS, an estimated 
amount of 10–20 % of the silver detected in the simu-
lant was shown to be particulate. To explore the impact of 
multiple utilization, the food simulant was removed and 
the box stored for some days before repeating the measure-
ment. In this experimental setup, the silver release dropped 
markedly. A worst-case assessment was thus based on the 
assumption of an initial use of the box for storage of acetic 
food. An easily consumable amount of 100 ml would result 
in an acute oral exposure to 4.2 μg of silver. While this 
seems low in comparison to reported silver concentrations 
in US drinking water in the 60s and 70s of the last century, 
von Götz reasoned that a comparison to apparently safe 
water levels could be foiled by the circumstance that a small 
fraction of the released silver might consist of nanoparticles.
The current knowledge on the human health hazard  
of nanosilver is growing but yet limited
Challenges and pitfalls
The presentations in this session provided both reviews on 
the existing database and insights into ongoing research 
aiming at a better understanding and estimation of the 
human health hazard potential of nanosilver for regulatory 
purposes. Particular challenges of nanospecific toxicologi-
cal testing were also addressed. The subsequent plenary 
discussion stressed the importance of reliable and com-
prehensive toxicological information for manufactured 
nanosilver, which in turn requires standardization and har-
monization of test materials and methods.
In terms of testing requirements, Helinor Johnston 
(Heriot-Watt University Edinburgh, UK) emphasized the 
necessity for extensive characterization of the nanomaterial 
in a given test medium, since physiochemical properties 
that drive toxicity may vary dramatically depending on the 
test system applied. Likewise, dispersion protocols need 
to be properly documented and justified. Furthermore, the 
interaction with biological molecules as well as interfer-
ence with chemical compounds and reagents of the assay 
system has to be addressed. Identification of crossover 
challenges in human and environmental studies may also 
be helpful (e.g., how to cope with agglomeration of nano-
particles). In this context, cross-species comparisons have 
also been encouraged (Gaiser et al. 2012). Exposure infor-
mation is relevant not only for risk assessment, but also for 
interpreting existing hazard information and for adjusting 
the dosing regimen when designing toxicological studies. 
Further investigation on the relationship between expo-
sure to a nanomaterial, its effects and its physico-chemi-
cal properties, may provide insight into structure–activity 
relationships and clues on the most appropriate dose met-
ric prompting to describe toxicity. In consideration of the 
large variety of different nanoforms of the same chemical 
identity as well as the limitations in resources and access 
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to sophisticated analytical instrumentation, testing and 
analysis will necessarily face constraints. These may be 
overcome by intelligent testing approaches. In vitro testing 
was identified as one important step in this direction since 
the results might support to generate a solid database for 
grouping of nanomaterials according to the toxicological 
potency and, ultimately, fostering the development of high 
throughput systems. However, currently used in vitro mod-
els or those that are under development need to be validated 
and their predictive values for in vivo toxicity yet to be 
determined (Kermanizadeh et al. 2012). It was also empha-
sized that there is a need to identify those physico-chem-
ical properties which trigger mode of action and specific 
adverse responses, in order to develop structure–activity 
relationships that are able to predict nanomaterial toxicity. 
Until this process becomes viable, the present methodo-
logical limitations have to be considered carefully in risk 
assessment.
The current toxicological database
Susan Wijnhoven (National Institute for Public Health and 
the Environment, The Netherlands) presented an overview 
on the available toxicological data for nanosilver (Wijn-
hoven et al. 2009). Various knowledge gaps precluding 
meaningful hazard assessment were identified. One of the 
most important knowledge gaps—the role of ion release 
in distribution and toxic responses to nanosilver—was 
addressed by intravenous injection of nanosilver of differ-
ent particles sizes into rats. Because of distinct distribution 
patterns observed for each particle size, it was concluded 
that the nanoparticles could not have degraded immedi-
ately (Lankveld et al. 2010). However, ion release behav-
ior may have varied itself with particle size and available 
surface. With respect to toxicity studies, the database could 
be improved in recent years, in particular by a number of 
repeated dose toxicity studies in rodents investigating dif-
ferent routes of exposure (Ji et al. 2007; Kim et al. 2008, 
2010; Sung et al. 2009; 2011). In addition, a recent dermal 
toxicity study in guinea pigs reported local as well as sys-
temic effects (Korani et al. 2011). The repeated dose stud-
ies may give valuable input for risk assessment but require 
thorough evaluation.
Based on these data, preliminary risk assessments have 
been published for nanosilver (Christensen et al. 2010; 
Pronk et al. 2009). Since being afflicted with uncertainty, 
they do not support waiving of further testing of systemic 
effects. For a more robust risk assessment, more valid 
data have to be generated both on the exposure and on 
hazard. For the latter, toxicokinetic investigation of differ-
ent types of adequately characterized nanosilver materials 
was encouraged. Other major gaps identified to be investi-
gated with priority include repeated dose toxicity, potential 
target organs (liver, lung, immune system), genotoxicity, 
reproductive toxicity, as well as oral, dermal and inhalative 
studies relevant and designed according to relevant occupa-
tional and consumer settings.
New toxicological data
Wim de Jong (National Institute for Public Health and 
the Environment, The Netherlands) presented data from 
a 17-day toxicokinetic study and a 28-day repeated dose 
study using nanosilver of different sizes (all from nano-
Composix). Nanoparticles were administered to rats by 
daily intravenous injection in order to analyze the systemic 
distribution and to identify organs at risk of adverse effects 
by these nanoparticles. The silver content in blood and 
organs was measured by inductively coupled plasma mass 
spectrometry (ICP-MS). Early target organs were liver and 
spleen, while after 5 days, particles had accumulated most 
in spleen, and also in liver and lungs. The silver content 
was highest in spleen, liver and lungs for particles of 80 and 
110 nm, while 20-nm particles were most prevalent in kid-
neys. The low recovery of the latter might be attributable to 
a higher rate of degradation due to a high surface-to-vol-
ume ratio. The concentration of silver in blood fell rapidly 
within minutes after intravenous administration, reaching a 
plateau at one-third of the initial concentration. After intra-
venous treatment for 28 days, relative body weight gains 
were lower in both sexes of rats in the high dose groups 
(2 and 6 mg/kg bw). In both particle size ranges of 20 and 
100 nm, liver weights remained unaffected while spleen 
weights in the 6-mg/kg bw dose group were increased. 
Organs as well as lymph nodes showed pigmentation in 
treated groups. The overall spleen, B and T cell numbers 
were significantly increased, while natural killer (NK) cells 
were only slightly increased. By contrast, spleen NK cell 
activity was decreased at 2 and 6 mg/kg bw for the 20-nm 
nanosilver particles and greatly diminished at 6 mg/kg bw 
for the 100-nm particle size (only dose level tested). Mito-
genic responses of spleen B and T cells to concanavalin A 
remained unaffected. In the blood, the mean corpuscular 
volume and mean corpuscular hemoglobin of erythrocytes 
were decreased as were relative lymphocyte numbers (from 
90 to 78 %), while IgM, IgE, absolute and relative granu-
locyte numbers were increased. Overall, the intravenous 
study indicated that nanosilver may have an immunotoxic 
potential.
Mary Boudreau (Federal Drug Administration, USA) 
summarized results from studies of the US National 
Toxicology Program (NTP) on well-characterized sil-
ver nanoparticles of discrete sizes in rats. A toxicoki-
netic study investigated citrate-stabilized particles of 10, 
75 and 110 nm and of silver acetate. Administration was 
oral (10 mg/kg) or intravenous (3 mg/kg), and silver mass 
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was determined in blood by ICP-MS. In the intravenous 
study, blood silver concentrations decreased rapidly for 
nanoscaled silver and less so for the salt. This was fol-
lowed by re-appearance of silver in the circulation and a 
subsequent plateau with similar blood silver content for 
all tested forms on days 2 and 3. In the oral study, tmax 
(12 h), t1/2 (4–5 h) and elimination time (24 h) were simi-
lar among silver particles. The area under the curve (AUC) 
and cmax increased with decreasing particle size, but did not 
reach the levels observed with silver acetate. The ADME 
study investigated the fate of a single oral administration 
of 20 mg/kg and discovered minimal absorption from this 
regimen with 0.002–0.006 % of the dose absorbed for 
nanosilver and approximately 0.016 % for silver acetate at 
a recovery of 90–120 %. Traces accumulated in the blood, 
excretory organs and urine. The major route of elimina-
tion was via feces within 48 h. In the 90-day subchronic 
study, 9, 18 or 36 mg/kg of 10-, 75- or 110-nm silver par-
ticles with properties comparable to the particles evaluated 
in the ADME study, or 100, 200 or 400 mg/kg of silver 
acetate were administered by gavage. Characterization of 
all materials by transmission electron microscopy (TEM), 
dynamic light scattering (DLS) and ICP-MS confirmed test 
article and dose certifications deviating less ±10 % of tar-
get values. One preliminary finding was a reduced weight 
gain and an increase in morbidity in rats with silver acetate 
doses ≥200 mg/kg, but not in animals treated with nanosil-
ver particles. Gastroenteritis was identified as the cause of 
death from silver acetate. Renal disease was noted in the 
case of three rats treated with nanoparticles but a dose-
response relationship was not yet established. Further anal-
ysis including effects on gut microflora, gross pathology 
and histopathology, clinical chemistry and hematology as 
well as TEM of selected tissues was not completed.
In a further presentation, Saber Hussain (Air Force 
Research Laboratory, USA) presented data on the effects 
of size, shape, surface coating and charge on silver particle 
toxicity. He pointed out that a comprehensive mechanistic 
understanding of how physical parameters of nanosilver 
particles are linked to biological effects is still lacking. 
In vitro observations on rat hepatocytes, alveolar mac-
rophages and keratinocytes suggested that silver nanoma-
terials exhibit size-dependent toxicity (primary particle 
size and agglomerate size) and elevated reactive oxygen 
species (ROS) generation (Carlson et al. 2008; Hussain 
et al. 2005). Interestingly, there was no linear size-response 
relationship. Among primary particle sizes of 20, 40 and 
80 nm, the agglomerates from medium-sized primary par-
ticles showed the highest activity. A comparison of 4- and 
20-μm silver nanowires in a human alveolar lung co-cul-
ture model did not provide evidence for a major influence 
on epithelial cell viability—possibly due to effective par-
ticle scavenging by co-cultured macrophages—but showed 
alterations in cytokine expression and matrix metallopro-
teases turnover. Quantitative differences in IL-6 responses 
indicated a possible influence of shape on effect size. Fur-
thermore, differences in cytotoxicity toward germline stem 
cells were demonstrated between hydrocarbon-coated 
and polysaccharide-coated nanosilver with different sizes 
between 10 and 30 nm (Braydich-Stolle et al. 2010). It 
was also noted, however, that over time the coating may 
degrade in the cellular environment, as analyzed by X-ray 
photoelectron spectroscopy (XPS). Finally, interference 
of silver and nanosilver with the epidermal growth factor 
(EGF) signaling pathway was proposed as the underlying 
mechanism for ROS generation and, ultimately, loss of 
cell viability. Silver nanoparticles were observed to reduce 
EGF-dependent phosphorylation of Akt (protein kinase B) 
and Erk (extracellular regulated kinase), regulators of cell 
metabolism, survival and proliferation.
The extensive application of nanosilver might contribute 
to the spread of silver resistance mechanisms
Silver resistance mechanisms
In this session, it was initially discussed whether the puta-
tive spread of silver resistance mechanisms, due to the 
extensive application of nanosilver, may be of major con-
cern. Silver is an effective, broad-spectrum antimicro-
bial agent commonly used in many medical applications, 
for instance, as topical antimicrobial agent in bandages 
for burn wounds, trauma and diabetic wounds or tonsilli-
tis but also in silver-coated catheters and medical devices, 
dental silver amalgams and was historically used as an 
agent for treatment of syphilis (e.g., silver arsphenamine). 
In addition to these essential medical benefits, there is an 
increasing application of nanosilver in consumer products 
as coating of clothing (e.g., sports fabrics, sleeping bags, 
socks), in household products and electric devices (refrig-
erators, boards, PC boards), as an agent to disinfect water, 
as growth promoter in agriculture or as coating of food 
packaging materials.
A brief introduction recalled the mode of action of silver 
toxicity in microorganisms. Despite its use as antimicrobial 
agent over decades, our current understanding on the mech-
anism of silver toxicity in microorganisms is still limited. 
The main cytotoxic effect results from interaction of silver 
ions with thiol (sulfhydryl) groups and other functional 
groups in enzymes and proteins, disrupting essential cellu-
lar processes such as respiration and the establishment of 
proton motive force (Jung et al. 2008). Silver treatment also 
results in the release of potassium ions from bacterial cells, 
suggesting that the cytoplasmic membrane is compromised 
upon silver exposure (Schreurs and Rosenberg 1982). An 
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additional impact might come from its interactions with 
nucleic acids, though the contribution of this target mol-
ecule to toxicity remains ambiguous unclear (Yakabe et al. 
1980).
Silver resistance has been reported as early as the 1970s 
in various clinical relevant species including Escherichia 
coli, Salmonella typhimurium, Enterobacter cloacae, Pseu-
domonas stutzeri and Acinetobacter baumannii (McHugh 
et al. 1975; Annear et al. 1976; Bridges et al. 1979; Hen-
dry and Stewart 1979; Haefeli et al. 1984; Kaur et al. 1985; 
Deshpande and Chopade 1994). Resistance mechanisms 
include efflux mechanisms (e.g., encoded by sil genes) and 
extracellular or periplasmic silver binding peptides (silE). 
In addition, mechanisms capable to reduce silver ions into 
less reactive metallic particles which are subsequently 
deposited periplasmatically are also assumed to contrib-
ute to silver resistance, as described mainly for P. stutzeri 
(Klaus et al. 1999). The resistance determinants may be 
located on chromosomes and on genetic transmissible 
elements. The as yet best known resistance mechanism is 
encoded on a 180-kb IncH1 plasmid called pMG101 (Sil-
ver 2003). This conjugative plasmid also confers resistance 
to mercury, tellurite and several antibiotics and is trans-
ferable to a wide spectrum of host bacteria (Gupta et al. 
1998, 1999, 2001). It is likely that more resistance mecha-
nisms will emerge in the future as more and more bacteria 
genomes are getting sequenced and characterized.
Prevalence of silver resistance
The good news from the conference was that at present 
prevalence of silver resistance is low (Ip et al. 2006; Jakob-
sen et al. 2011). Yet, although resistance rates among clini-
cal isolates have remained low despite long-term use, silver 
resistance determinants may be located on mobile genetic 
elements that confer resistance to multiple other antibiotics. 
Lotte Jakobsen (Statens Serum Institut, Copenhagen, Den-
mark) described the IncHI2 plasmid from an extraintestinal 
pathogenic E. coli isolate which conferred resistance to sul-
fonamides, streptomycin, gentamicin, tetracycline, potas-
sium tellurite, copper sulfate and benzalkonium chloride 
besides silver nitrate (Johnson et al. 2006). Another cited 
study reported a major nosocomial outbreak associated 
with the multi-resistant highly pathogenic E. coli ST131 
lineage with evidence of multiple cases of transfer of a 
multi-resistant silver resistant plasmid to patients’ intestinal 
flora (Sandegren et al. 2012). The finding of co-resistance 
demonstrates that selection of silver resistance by other 
antimicrobials is likely. A further case of concern, which 
was addressed, lies in the development of cross-resistance 
(Li et al. 1997). Of particular concern is the cross-resist-
ance toward carbapenems which are now the antibiot-
ics of choice to treat one of the fastest growing resistance 
problems with both community and hospital acquired 
infections emerging worldwide, that is, the extended-spec-
trum β-lactamase (ESBL) producing Enterobacteriaceae 
(Sütterlin et al. 2012). Taken together, silver resistance may 
be co-selected by the use of many antimicrobial agents just 
like silver use may co-select or cross-select for resistance 
toward critically important antimicrobials for human medi-
cine. This may occur in a clinical setting as well as in ani-
mal production where growth promoters (e.g., copper) are 
intensively used since the ban of antimicrobials (Johnson 
et al. 2006). Thus, monitoring of resistance (and consump-
tion) in patients and in the environment is needed to avoid 
future spread of silver resistance.
Impact on the composition of the human skin microbiome
Dirk Höfer (Hohenstein Institute, Germany) discussed the 
putative adverse impact on the composition of the human 
skin microflora due to the extensive application of silver 
or nanosilver especially as coating of clothing (e.g., sports 
fabrics, sleeping bags, socks). It is well known that the nor-
mal skin microflora acts as a barrier against colonization of 
potentially pathogenic microorganisms and against over-
growth of already present opportunistic microorganisms 
(Sullivan et al. 2001). This kind of control of growth of 
opportunistic microorganisms is termed colonization resist-
ance. Consequently, one might expect that the release of 
antimicrobial silver or nanosilver from textiles might affect 
the microbiome on the human skin. During the conference, 
results from a study on the short- and long-term effects of 
antimicrobial active clothes on the ecological balance of 
the healthy human skin microflora were reported. The wear 
trials with 60 volunteers carrying silver-coated textile sam-
ples releasing 1.9 or 2.5 ppm of silver showed no signifi-
cant impact on their skin microflora (Hoefer and Hammer 
2011).
Impact on the wastewater treatment
Besides the putative spread of resistance mechanisms 
toward silver and antibiotics, silver and nanosilver in 
wastewater are highlighted as a concern due to the poten-
tial impact on the biological treatment processes and its 
poorly known elimination efficiency in wastewater treat-
ment plants (WWTP). Of particularly concern is the dis-
charge of nanosilver in the form of individual particles 
thereby receiving waters and effects on non-target organ-
isms by released silver ions. Knowledge on the occurrence 
of silver particles in wastewater and WWTP is still scarce. 
Michael Burkhardt (HSR University of Applied Sciences 
Rapperswil, Switzerland) presented a study on the influ-
ence of nanosilver on the treatment performance of a real 
WWTP (60,000 inhabitants equivalent) and a pilot scale 
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WWTP (70 inhabitants equivalent), and on how nanosil-
ver is distributed in the system, particularly in the excess 
sludge and treated effluent waters (Burkhardt et al. 2010; 
Kaegi et al. 2011). The effect of four different silver addi-
tives (AgCl 20–500 nm; nano-AgA 5–50 nm; OECD ref-
erence material NM-300 K; nano-AgB 5–50 nm) on the 
nitrification (ammonia oxidation) in activated sludge has 
been studied in batch reactors. The concentrations of silver 
were measured by ICP-OES, particulate silver was inves-
tigated using analytical electron microscopy in combina-
tion with energy disperse X-ray spectroscopy (SEM-EDX, 
TEM-EDX), and the speciation was assessed using X-ray 
absorption spectroscopy (XAS). On real scale, concentra-
tions <20 μg/l silver even under worst-case conditions of 
industrial silver discharge were determined in the influent 
of the real WWTP. Silver was shown to be eliminated with 
an efficiency of 95–99 %, efficiently transformed within 
less than 30 min to insoluble silver sulfide (Ag2S) which 
was mostly attached to sludge flocs enabling further fil-
tration in the pilot scale and full scale WWTP. Individual 
nanosilver, not associated with sludge flocs, was observed 
occasionally only. The elimination of silver revealed very 
high compared to organic micropollutants omnipresent 
in wastewater. All XAS measurements from the full scale 
WWTP, including samples of the influent, effluent and the 
digested sludge, confirmed that silver exists as Ag2S. The 
investigated nanosilver additives are readily converted into 
Ag2S in the real-life wastewater matrix. Silver concentra-
tions <0.5 μg/l in effluent waters of municipal WWTP are 
measured. Ag2S is nearly insoluble with a benign ecotoxic-
ity profile compared to free silver ions. Effects on the nitri-
fication process (microbial activity) were not detected even 
after the addition of 1 mg/l silver corresponding to 250 mg 
silver in dried sludge. Since the vast majority of nanosilver 
was found: (1) to be attached to the activated sludge flocs, 
(2) eliminated by more than 95 % with excess sludge and 
(3) fully transformed to Ag2S with apparently no release of 
silver ions; Burkhardt concluded that there is no need for 
action to take special measures for nanosilver removal in 
the area of WWTP. However, it was argued in the subse-
quent discussion that a number of published results only 
refer to tests under artificial laboratory conditions (matrix, 
concentration, coating) which give only limited insight into 
environmental behavior in real wastewater.
Nanosilver containing products are or will be regulated 
by different legislations around the globe
Depending on their actual use and functionality claims, 
nanosilver as the active substance and/or nanosilver con-
taining products are or will be regulated by different leg-
islations around the globe. Examples are the European 
Cosmetics Regulation (Regulation (EC) No 1223/2009), 
the European Biocidal Product Regulation (BPR, Regu-
lation (EU) No 528/2012) or the US Federal Insecticide, 
Fungicide and Rodenticide Act (FIFRA).
Assessment and regulation of nanomaterials under  
the European Biocides Regulation
Isabel Günther (BfR, Germany) provided the details on 
the new Regulation (EU) No 528/2012, which replaces 
the older Biocidal Product Directive (BPD, 98/8/EC) 
from September 2013 on. For the first time in Europe, the 
BPR explicitly makes provisions not only for labeling, 
but also for the assessment of products containing nano-
materials. Like the preceding Biocidal Product Directive, 
the new BPR foresees a two-step procedure for the final 
authorization of a biocidal product. In the first step lead-
ing to approval (previously: Annex I listing), the active 
substances undergo a rigorous hazard characterization 
with peer review by all member state competent authori-
ties, and at least one safe use has to be demonstrated for 
a respective example product. Considering the uncertainty 
about the risk-related properties of nanomaterials, the new 
regulation clarifies that any approval for a biocidal active 
substance will not include its nanoform unless specified, 
and a separate dossier will usually need to be submitted. 
Applicability and reliability of the methods used for testing 
of nanoscaled active substances are to be justified by the 
applicant, and adaptations to existing test protocols have to 
be made, if required. In addition, new test methods specific 
for nanomaterials will have to be developed. It becomes 
readily apparent that the risk assessment of nanomaterials 
to be performed under this regulation may become chal-
lenging, and for harmonized evaluation specific guidance 
has to be developed. Any biocidal products authorized in 
the second step of the assessment according to the BPR 
will have to be labeled as “nano” next to any nanoscaled 
ingredient.
EPA’s approach to nanosilver risk assessment  
and regulation
Jed Costanza (Environmental Protection Agency, United 
States; Costanza et al. 2011) illustrated key elements 
with respect to human health risks of a US EPA deci-
sion about the first registration for an explicitly nanosil-
ver pesticide to be used as textile preservative (EPA-HQ-
OPP-2009-1012-0064). The material was described as 
1–10-nm silver particles with some particles in the 50-nm 
range sintered onto amorphous silica. The risk assess-
ment of the pesticide considered occupational as well as 
consumer exposure to the material, as well as silver nano-
particles, and ionic silver released by degradation. It was 
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based on the currently available data, making conservative 
assumptions to compensate for knowledge gaps. The toxic-
ity information submitted by the applicant included animal 
data on acute oral, dermal and inhalation toxicity as well 
as eye irritation with the product. This was complemented 
by a characterization of the potential occupational exposure 
from handling nanosilver powder via the inhalation and the 
dermal route. For consumer exposure, a scenario in which 
a 3-year-old toddler is exposed daily to a fresh nanosilver-
coated jumpsuit was considered worst case and formed the 
basis for risk characterization. The US EPA found that the 
nanosilver risk assessment presented unique challenges 
with regard to not only the experimental database, but also 
the methodology of assessment, thus prompting the instal-
lation of an external advisory panel. The panel concluded 
that hazard information for ionic and metallic silver cannot 
be read across to the nanomaterial. Only a minority of the 
panel supported bridging to silver materials of similar size 
and essentially identical physicochemistry. On this basis, 
risk was assessed using the NOAEL from a 90-day rat 
inhalation study on uncoated nanosilver of 6–55 (mean 18) 
nm (Sung et al., 2009) and a 28-day mouse oral (presum-
ably gavage) study with silver particles measuring on aver-
age 42 nm (Park et al. 2010). Interestingly, the immunolog-
ical effects reported in the oral study on mice provided an 
endpoint that was by a factor of 60 more sensitive than an 
oral 90-day study in rats with 56-nm silver particles (Kim 
et al. 2010) performed according to OECD test guideline 
408. A dermal repeated-dose toxicity study with nanosil-
ver was not available. The US EPA also identified concerns 
and data gaps for neurotoxicity, developmental and repro-
ductive toxicity, as well as deficiencies in the database on 
mutagenicity of nanosilver. An additional uncertainty fac-
tor of 10 was applied to account for these deficiencies in 
risk characterization, resulting in a “no risk” statement for 
consumer as well as for textile manufacturing workers (tak-
ing into account appropriate risk mitigation measures).
EPA’s finding that the proposed use of the pesticide 
would not cause unreasonable adverse effects on the envi-
ronment that did not require consideration of the benefits 
from the use of the pesticide because no risk concern 
was identified. However, EPA did consider some benefits 
from the use of the pesticide in determining that granting 
a conditional registration pending development of addi-
tional data would be in the public interest. For example, 
one public interest benefit identified was an up to 200-fold 
reduction in silver released into the environment due to the 
replacement of registered conventional forms of silver by 
the nanosilver material.
This conditional registration requires the manufacturer 
to close gaps in the data set for the product in a tiered 
4-year testing program. Tier 1 includes endpoints such 
as particle size distribution and surface area, degradation 
kinetics, leaching and dermal/inhalation/laundry exposure 
estimation, as well as a 90-day inhalation and dermal toxic-
ity assay, a reproductive/developmental toxicity screening 
test and an in vitro micronucleus assay. Tier 2 may require 
similar testing for any nanoscaled silver released from the 
composite product.
The Swedish chemicals agency’s (Kemikalieinspektionen 
KEMI, Sweden) approach to nanosilver risk assessment 
and regulation
Ulrike Frank pointed out the fact that in consumer goods 
silver is used with the aim to employ a biocidal effect. This 
effect can be reached by the release of silver ions from dif-
ferent silver compounds or silver forms in contact with 
water. The application of nanoscaled silver or nanosilver 
composites is only one possibility besides the use of silver 
salts, silver ion exchangers, silver composites and elemen-
tal silver.
Silver is a broad-spectrum microbiocide and has the 
advantage that the technical handling is comparatively easy. 
Moreover, so far silver has a better reputation than organic 
biocides. This makes it feasible to add silver to a great vari-
ety of consumer goods, either via incorporation into the 
polymer material, or via a silver containing coating.
The selling point of silver-treated articles is the demand 
for “hygienic” goods, or the general fear of bacteria. This 
fear is differently strong in different cultures. The demand 
for such products is generally higher in the United States 
and in East Asia than in Europe.
The majority of silver containing biocidal products con-
tain silver in microscale rather than in nanoscale. The aim 
of nanoscaled silver as well as of microscaled silver is to 
release silver ions, as the ions cause the biocidal effect. 
Consumers are in the first place exposed to silver ions. In 
the environment, silver ions are rapidly complexed with 
inorganic sulfides and organo-sulfur compounds. Whether 
consumers and the environment are exposed to nanoscaled 
silver has to be shown during the evaluation. Generally, the 
modeling of exposure is very demanding due to the great 
variety of consumer articles and their different uses.
Austria’s approach to nanosilver risk assessment  
and regulation
Alexander Zilberszac (Austrian Federal Ministry of Health, 
Austria) talked about the Austrian approach to risk gov-
ernance for nanosilver. Risk governance is based on the 
process of risk assessment and includes policy-driven risk 
management as well as communication of risk manage-
ment decisions. It also involves the dialog with or between 
stakeholders. Whenever the scientific basis of risk assess-
ment is limited by methodological or data constraints, risk 
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management and communication measures will dominate 
the governance process. In the case of nanosilver-based 
consumer products, a study commissioned by the Federal 
Ministry of Health concluded that “… an extensive use 
of nanosilver at low concentrations in consumer products 
might promote the development of allergies and multi-
resistant bacteria.” This conclusion was supported by the 
opinion of the BfR concerning this matter (BfR 2010). 
Considering that silver and nanosilver have a high value 
for certain medical applications, notably treatment of burn 
victims, the situation of scientific uncertainty prompted a 
policy response. On July 8, 2011, the Austrian Parliament 
unanimously adopted a resolution requesting the govern-
ment “to take all necessary measures to ensure the thera-
peutic efficacy of nanosilver in human medicine.” The gov-
ernment is now following parallel approaches to implement 
the Parliament resolution, namely enforcement of existing 
regulation, communication with consumers as well as sup-
porting relevant research activities and voluntary/private 
initiatives. With regard to law enforcement, the provisions 
of the Regulation on the Provision of Food Information to 
Consumers with respect to labeling of technical nanoma-
terials (Regulation (EU) No 1169/2011) in addition to the 
Cosmetics Regulation (1223/2009) and the Biocidal Prod-
ucts Regulation (528/2012) were emphasized. The Federal 
Ministry of Health further took lead in the installation of 
the nanoinformation platform (NIP), which is intended to 
provide an information portal for the interested general 
public to facilitate opinion making. A NANO Environment, 
Health and Safety Program (NANO EHS) was set up based 
on the Austrian Nanotechnology Action Plan. It is the stra-
tegic objective of this program to fill knowledge gaps that 
limit the environmental, occupational and consumer risk 
assessment for applications of nanomaterials including 
nanosilver. Last but not least, measures have been installed 
to ensure that administrations purchase goods and services 
taking into account potential risks from nanosilver. In 
particular, the city of Vienna must “…make sure to avoid 
buying cutting boards or packaging materials with antimi-
crobial nanosilver coatings,” and may “…not allow antimi-
crobial paint additives (e.g., nanosilver) for routine appli-
cations.” Similar provisions apply for nanosilver coatings 
in textiles and household appliances. It is also intended to 
include respective text passages in all sets of criteria for the 
Austrian eco-label “Öko-Kauf Wien.”
Conclusions
Identity and analytics
The enormous number of possible variants of silver 
nanoparticles is the result of the simplicity of silver 
nanoparticle syntheses. This huge variety of different sil-
ver nanoparticle entities may also be the reason for the 
absence of certified reference materials for silver. Thus, 
any real generalizations on what sort of behavior would be 
expected from any particular material are very difficult to 
make. A careful characterization on a case-by-case basis is 
needed to avoid errors coming from the apparently differ-
ent behavior of nanoparticles due to the use of unknown 
stabilizing agents. Additionally, the knowledge about the 
dissolution rates of silver is likely to be extremely criti-
cal as variations in the dissolution behavior are strongly 
related to the physico-chemical properties of the examined 
nanoparticles.
The biggest challenge so far is to gain a better under-
standing of the reciprocal effects of nanoparticles when 
in contact with biological media. Single particle ICP-
MS has made a promising progress to overcome some of 
these hurdles and is able to detect inorganic, non-porous 
nanoparticles which are composed of one material in 
complex media. With the completion of current ongoing 
EU projects, the first finalized validation studies com-
bined with standard operation procedures are expected 
to become available. However, there are still major gaps 
related to commonly agreed guidelines for sample prep-
aration and central analytical techniques like electron 
microscopy.
Human exposure
Silver nanoparticles are released from a growing number 
of commercially available products. Skin and respiratory 
tract were identified as relevant routes for exposure. In this 
context, the barrier function of the skin, in particular of 
damaged skin, has to be taken into account in any expo-
sure assessment. Likewise, the inhalative route will have 
to be addressed in more detail in order to model exposure 
levels. Next to production techniques, multiple usage and 
product aging were identified as impact factors for nano-
particle release. These observations indicate a need for 
case-by-case exposure assessments. Further research has 
to consider aging processes as a basis for scientific estab-
lishment of worst-case assumptions and refinements to 
more realistic exposure levels. Respirable particles may 
occur due to spraying or abrasion processes. Sanding 
procedures of macroscopic surface coatings revealed no 
generation of free engineered nanoparticles (additives or 
pigments), previous aging lead to coarser particle size dis-
tributions irrespective of the original nanoparticle content. 
Workplace measurement techniques for aerosols and dry 
powders are already part of tiered approaches to quantify 
exposure levels. However, consumer exposure scenarios 
are only starting to be developed and exposure measure-
ment data are still rare.
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Toxicological aspects
Clearly, the availability of valid toxicological data and 
information on toxicokinetics has been improved in recent 
years thus reducing the degree of uncertainty in hazard and 
risk assessment for nanoforms of silver. Comparability of 
studies requires thorough characterization of test materials 
as well as further adjustments and developments in testing 
design, methodology and analysis. The toxic principle of 
nanosilver, that is, whether toxicity is ion or particle driven, 
yet has to be elucidated and analysis of the toxicologi-
cal profile has to be adjusted accordingly. With regard to 
particles characteristics, it was noted that physical param-
eters are directly linked to its biological and toxicological 
effects. Particularly, the size of primary particles and their 
most prevalent agglomerates, the size distribution, shape 
and coating may alter the strength of an effect by orders 
of magnitude. Silver nanoparticles accumulate in liver and 
spleen and may affect immunogenic factors after having 
become systemically available. Key aspects to be addressed 
in the future are the unequivocal detection of nanosilver 
particles, their absorption, fate and toxic response. This 
includes addressing issues such as secondary particle for-
mation, “Trojan horse” effects and interaction of silver 
particles with biological structures. One has to intensify 
particle toxicology and learn to understand the differ-
ences to soluble chemicals toxicology. This is most strik-
ing in terms of barrier penetration, unusual exposure routes 
(e.g., the olfactory bulb) and accumulation in the body. As 
existing information showed distribution of silver to brain 
and testis, testing should also address potential neuro- and 
reproductive toxicity of nanosilver. The appropriate inves-
tigations include kinetics, long-term toxicity testing, stand-
ardized, harmonized and predictive in vitro models and 
their correlation with in vivo data.
Microbiological aspects
Various clinical relevant species use either efflux mecha-
nisms, extracellular or periplasmic silver-binding peptides 
or mechanisms capable of reducing silver ions into less 
reactive metallic particles. It is likely that more resistance 
mechanisms will emerge in the future as more and more 
bacteria genomes are getting sequenced. It was common 
sense on the workshop that the use of silver may lead to 
the selection of silver resistant bacteria. Since conjugative 
silver resistance plasmids also confer resistance to several 
antibiotics and are transferable to a wide spectrum of host 
bacteria, the selection of silver resistant bacteria may coin-
cide with the selection of antibiotic resistant bacteria. Yet, 
resistance rates among clinical isolates have remained low 
despite long-term use. A further issue of concern, which 
was addressed, lies in the development of cross-resistance. 
Especially worrisome is the cross-resistance toward car-
bapenems. Thus, monitoring of resistance (and consump-
tion) in patients and in the environment is needed to avoid 
future spread of silver resistance.
With respect to environmental behavior of silver, it was 
proposed that there is no need for action to take special 
measures for nanosilver removal in the area of WWTP, since 
the vast majority of nanosilver is converted into insoluble 
Ag2S, found to be attached to biological particles and more 
than 95 % of silver is eliminated by activated sludge during 
the wastewater treatment process. Based on these results, it 
was suggested that nanosilver released to wastewater may 
have negligible ecotoxicological effects in the aquatic envi-
ronment. However, in the subsequent discussion, it was 
argued that a number of published results only refer to tests 
under artificial laboratory conditions which do not reflect 
the process conditions from real life and, therefore, may 
present misleading results to relevant mechanisms.
Risk assessment and regulation of nanosilver
The presentations and discussion on risk assessment and 
regulation of nanosilver applications showed that different 
approaches can be assumed in a data deficient situation. 
Taking a more “precautionary approach” law enforcement 
and communication measures were chosen in Austria to 
limit the use of nanosilver while supporting further research 
in the frame of a Nanotechnology Action Plan. In the United 
States, registration of a nanosilver textile preservative was 
granted weighing uncertainties arising from knowledge gaps 
against benefits, namely potential reductions in the overall 
use quantity of silver as a biocide, and—at the same time—
linking this registration with the implementation of a testing 
program to be conducted by the manufacturer. In Europe, 
the regulation of biocides has been enhanced to specifically 
address definition, assessment and labeling of nanobiocides 
such as nanosilver in the near future.
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